ArticleCancers2023

Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study.

Fabio Andreozzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.